Body Mass Index Trends and Role of Obesity in Predicting Outcome After Radical Prostatectomy

Urology

Volumn 72, Issue 5, 2008, Pages 1106-1110

  Motamedinia, Piruz ^a   Korets, Ruslan ^b   Spencer, Benjamin A ^b   Benson, Mitchell C ^b   McKiernan, James M ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; ARTICLE; BODY MASS; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OBESITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE RISK; TREATMENT FAILURE; TREATMENT OUTCOME;

BODY MASS INDEX; COHORT STUDIES; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OBESITY; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE;

EID: 54449098891     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.04.021     Document Type: Article

References (28)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
2. Kattan M.W., Eastham J.A., Stapleton A.M., et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90 (1998) 766-771
3. Ward J.F., Blute M.L., Slezak J., et al. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. J Urol 170 (2003) 1872-1876
4. Flegal K.M., Graubard B.I., Williamson D.F., et al. Excess deaths associated with underweight, overweight, and obesity. JAMA 293 (2005) 1861-1867
5. Adams K.F., Schatzkin A., Harris T.B., et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355 (2006) 763-778
6. Rapp K., Schroeder J., Klenk J., et al. Obesity and incidence of cancer: A large cohort study of over 145,000 adults in Austria. Br J Cancer 93 (2005) 1062-1067
7. Calle E.E., Rodriguez C., Walker-Thurmond K., et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348 (2003) 1625-1638
8. Rodriguez C., Patel A.V., Calle E.E., et al. Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev 10 (2001) 345-353
9. Giovannucci E., Rimm E.B., Liu Y., et al. Body mass index and risk of prostate cancer in U.S. health professionals. J Natl Cancer Inst 95 (2003) 1240-1244
10. Freedland S.J., Terris M.K., Presti Jr. J.C., et al. Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins. J Urol 172 (2004) 520-524
11. Loeb S., Roehl K.A., Nadler R.B., et al. Prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng/ml. J Urol 178 (2007) 2348-2353
12. Siddiqui S.A., Inman B.A., Sengupta S., et al. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study. Cancer 107 (2006) 521-529
13. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-The Evidence Report. Obes Rev 6 suppl 2 (1998) 51S-209S
14. Beahrs O.H., Hutter R.V.P., and Kennedy B.J. Manual for Staging Cancer. 4th ed. DEH (1992), JB Lippincott, Philadelphia
15. Kattan M.W., Wheeler T.M., and Scardino P.T. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 17 (1999) 1499-1507
16. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555
17. Mokdad A.H., Serdula M.K., Dietz W.H., et al. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 282 (1999) 1519-1522
18. Smith R.A., Cokkinides V., and Eyre H.J. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 56 (2006) 11-25 quiz 49-50
19. American Urological Association. Prostate-specific antigen (PSA) best practice policy. Oncology (Willstn Pk) 14 (2000) 267-272 277-278, 280, passim
20. Baillargeon J., Pollock B.H., Kristal A.R., et al. The association of body mass index and prostate-specific antigen in a population-based study. Cancer 103 (2005) 1092-1095
21. Freedland S.J., Aronson W.J., Kane C.J., et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: A report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol 22 (2004) 446-453
22. Freedland S.J., Grubb K.A., Yiu S.K., et al. Obesity and capsular incision at the time of open retropubic radical prostatectomy. J Urol 174 (2005) 1798-1801
23. Mitchell R.E., Shah J.B., Olsson C.A., et al. Does year of radical prostatectomy independently predict outcome in prostate cancer?. Urology 67 (2006) 368-372
24. Stephenson A.J., Scardino P.T., Eastham J.A., et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 23 (2005) 7005-7012
25. Tchernof A., and Despres J.P. Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women. Horm Metab Res 32 (2000) 526-536
26. Wagner D.R., and Heyward V.H. Measures of body composition in blacks and whites: A comparative review. Am J Clin Nutr 71 (2000) 1392-1402
27. Werny D.M., Thompson T., Saraiya M., et al. Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004. Cancer Epidemiol Biomarkers Prev 16 (2007) 70-76
28. Baquet C.R., Horm J.W., Gibbs T., et al. Socioeconomic factors and cancer incidence among blacks and whites. J Natl Cancer Inst 83 (1991) 551-557